Protected: Boehringer Ingelheim Advances First Pan-KRAS Inhibitor BI 1701963 into Clinical Testing
This content is password-protected. To view it, please enter the password below. Password:
Browsing: Industry Spotlight
Protected: Immunotherapy combination now PBS listed for first-line treatment of metastatic non-squamous non-small cell lung cancer (1,2)
This content is password-protected. To view it, please enter the password below. Password:
Protected: Novel triplet therapy for newly diagnosed multiple myeloma patients now TGA approved
This content is password-protected. To view it, please enter the password below. Password:
Protected: Tecentriq® (atezolizumab) + chemotherapy now TGA approved for 1L extensive-stage small cell lung cancer
This content is password-protected. To view it, please enter the password below. Password:
Protected: New triplet therapy for patients with multiple myeloma now TGA approved
This content is password-protected. To view it, please enter the password below. Password:
Australian researchers use experimental drug to destroy tumours in pre-clinical trial
Scientists at QIMR Berghofer Medical Research Institute have used an experimental drug produced from the…